Filing Flows › Zimmer Biomet Holdings (ZBH) › Q3 2026 › vs Q3 2025
Zimmer Biomet Holdings (ZBH) Q3 2026 vs Q3 2025 (year over year)
Zimmer Biomet Holdings's revenue rose $61.5M (+3%) from $2.0B in Q3 2025 to $2.1B in Q3 2026. The biggest changes: SET +$36.8M (+7%); Hips +$30.3M (+6%); Knees −$24.9M (-3%). Operating margin 14.9% against 17.6% (-2.6 pts).
Zimmer Biomet Holdings, Q3 2026: revenue $2.1B (+3% year over year), operating margin 14.9%, net earnings $193M, operating cash flow $560M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 14.9% | 17.6% | -2.6 pts |
| Net margin | 9.4% | 11.6% | -2.2 pts |
| Free cash flow margin | 18.1% | 13.9% | +4.2 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Knees | $768M | $792M | −$24.9M | -3% |
| SET | $578M | $542M | $36.8M | +7% |
| Hips | $536M | $506M | $30.3M | +6% |
| Technology and Data Bone Cement and Surgical | $181M | $161M | $19.3M | +12% |
| Revenue | $2.1B | $2.0B | $61.5M | +3% |
| Operating profit | $308M | $351M | −$43.7M | -12% |
| Costs & expenses | $1.8B | $1.7B | $105M | +6% |
| Pre-tax earnings | $230M | $279M | −$49.1M | -18% |
| Other expense, net | $77.5M | $72.1M | $5.4M | +7% |
| Cost of revenue | $594M | $559M | $35.2M | +6% |
| Research & development | $106M | $116M | −$10.0M | -9% |
| SG&A | $855M | $811M | $43.6M | +5% |
| Other operating costs | $200M | $164M | $36.4M | +22% |
| Net earnings | $193M | $231M | −$38.3M | -17% |
| Income tax | $37.2M | $48.0M | −$10.8M | -22% |
| Depreciation & amortization | $282M | $284M | −$1.6M | -0.6% |
| Share-based compensation | $24.2M | $25.3M | −$1.1M | -4% |
| Working capital & other | $60.9M | −$121M | $182M | — |
| Operating cash flow | $560M | $419M | $141M | +34% |
| Free cash flow (company-reported) | $372M | $278M | $94.8M | +34% |
| Itions to instruments | $112M | $86.0M | $25.8M | +30% |
| Itions to other property, plant and equipment | $75.8M | $55.1M | $20.7M | +38% |
Questions
How much did Zimmer Biomet Holdings's revenue grow year over year in Q3 2026?
Zimmer Biomet Holdings's revenue rose $61.5M (+3%) from $2.0B in Q3 2025 to $2.1B in Q3 2026.
What drove Zimmer Biomet Holdings's revenue change in Q3 2026?
SET +$36.8M (+7%); Hips +$30.3M (+6%); Knees −$24.9M (-3%).